Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Jan 2024)

Mechanical Versus Bioprosthetic Aortic Valve Replacement in Patients Undergoing Bentall Procedure

  • Cheng‐Yu Chen,
  • Chun‐Yu Chen,
  • Feng‐Cheng Chang,
  • Yu‐Ting Cheng,
  • Victor Chien‐Chia Wu,
  • Chia‐Pin Lin,
  • Yi‐Hsin Chan,
  • Kuo‐Chun Hung,
  • Pao‐Hsien Chu,
  • Shao‐Wei Chen

DOI
https://doi.org/10.1161/JAHA.123.030328
Journal volume & issue
Vol. 13, no. 1

Abstract

Read online

Background The widely used Bentall procedure is the criterion standard treatment for aortic root pathology. Studies comparing the long‐term outcomes of bioprosthetic and mechanical valves in patients undergoing the Bentall procedure are limited. Methods and Results Patients who underwent the Bentall procedure with a bioprosthetic or mechanical valve between 2001 and 2018 were identified from Taiwan's National Health Insurance Research Database. The primary outcome of interest was all‐cause mortality. Inverse probability of treatment weighting was performed to compare the 2 prosthetic types. In total, 1052 patients who underwent the Bentall procedure were identified. Among these patients, 351 (33.4%) and 701 (66.6%) chose bioprosthetic and mechanical valves, respectively. After inverse probability of treatment weighting, no significant differences in the in‐hospital mortality (odds ratio, 0.96 [95% CI, 0.77–1.19]; P=0.716) and all‐cause mortality (34.1% vs. 38.1%; hazard ratio, 0.90 [95% CI, 0.78–1.04]; P=0.154) were observed between the groups. The benefits of relative mortality associated with mechanical valves were apparent in younger patients and persisted until ≈50 years of age. Conclusions No differences in survival benefits were observed between the valves in patients who underwent the Bentall procedure. Additionally, bioprosthetic valves may be a reasonable choice for patients aged >50 years when receiving the Bentall procedure in this valve‐in‐valve era.

Keywords